Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53

• Ruey-Shyang Soong,

  Affiliations Departments of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Department of General Surgery, Chang Gung Memorial Hospital at Keelung, Keelung City, Taiwan, Chang Gung University, College of Medicine, Taoyuan, Taiwan

  ⨯
• Janson Trieu,

  Affiliation Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Sung Yong Lee,

  Affiliations Departments of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Department of Internal Medicine, Korea University Medical Center, Seoul, South Korea

  ⨯
• Liangmei He,

  Affiliation Departments of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯
• Ya-Chea Tsai,

  Affiliation Departments of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯
• T.-C. Wu,

  Affiliations Departments of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Obstetrics and Gynecology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Molecular Microbiology and Immunology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯
• Chien-Fu Hung

  * E-mail: chung2@jhmi.edu

  Affiliations Departments of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯